New weight loss drugs are out of reach for millions of older Americans because Medicare won't pay
Obesity drugs like Wegovy and Zepbound are capturing the attention of celebrities and showing promising results in helping people shed pounds.
Stay updated with breaking news from Mark Mcclellan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Obesity drugs like Wegovy and Zepbound are capturing the attention of celebrities and showing promising results in helping people shed pounds.
Obesity drugs like Wegovy and Zepbound are capturing the attention of celebrities and showing promising results in helping people shed pounds.
As obesity rates rise among older adults, some lawmakers say the US cannot afford to keep a decades-old law that prohibits Medicare from paying for new weight loss drugs, including Wegovy and Zepbound.
Obesity drugs like Wegovy and Zepbound are capturing the attention of celebrities and showing promising results in helping people shed pounds.
Obesity drugs like Wegovy and Zepbound are capturing the attention of celebrities and showing promising results in helping people shed pounds.